0000899243-22-011432.txt : 20220317 0000899243-22-011432.hdr.sgml : 20220317 20220317171449 ACCESSION NUMBER: 0000899243-22-011432 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20220106 FILED AS OF DATE: 20220317 DATE AS OF CHANGE: 20220317 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Morningside Venture Investments Ltd CENTRAL INDEX KEY: 0001543112 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-41199 FILM NUMBER: 22749847 BUSINESS ADDRESS: STREET 1: MCCARTHY LEGAL SERVICES STREET 2: 1188 CENTRE STREET CITY: NEWTON CENTRE STATE: MA ZIP: 02459 BUSINESS PHONE: 617-244-2800 MAIL ADDRESS: STREET 1: MCCARTHY LEGAL SERVICES STREET 2: 1188 CENTRE STREET CITY: NEWTON CENTRE STATE: MA ZIP: 02459 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MVIL, LLC CENTRAL INDEX KEY: 0001914583 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-41199 FILM NUMBER: 22749846 BUSINESS ADDRESS: STREET 1: 22ND FLOOR HANG LUNG CENTRE STREET 2: 2-20 PATERSON STREET CITY: CAUSEWAY BAY STATE: K3 ZIP: 00000 BUSINESS PHONE: 852-2576-6800 MAIL ADDRESS: STREET 1: 22ND FLOOR HANG LUNG CENTRE STREET 2: 2-20 PATERSON STREET CITY: CAUSEWAY BAY STATE: K3 ZIP: 00000 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Amylyx Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001658551 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 464600503 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 43 THORNDIKE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02141 BUSINESS PHONE: 617-683-0917 MAIL ADDRESS: STREET 1: 43 THORNDIKE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02141 4/A 1 doc4a.xml FORM 4/A SUBMISSION X0306 4/A 2022-01-06 2022-01-25 0 0001658551 Amylyx Pharmaceuticals, Inc. AMLX 0001543112 Morningside Venture Investments Ltd C/O THC MANAGEMENT SERVICES S.A.M. 3-5 AVENUE DES CITRONNIERS MONACO O9 MC 98000 MONACO 0 0 1 0 0001914583 MVIL, LLC C/O 22ND FLOOR, HANG LUNG CENTRE 2-20 PATERSON ST. CAUSEWAY BAY, HONG KONG K3 HONG KONG 0 0 1 0 Common Stock 2022-01-11 4 C 0 10415650 A 10415650 I See Footnotes Common Stock 2022-01-11 4 P 0 263158 19.00 A 10678808 I See Footnote Series A Preferred Stock 2022-01-11 4 C 0 1409035 0.00 D Common Stock 1409035 0 I See Footnote Series B Preferred Stock 2022-01-11 4 C 0 6410964 0.00 D Common Stock 6410964 0 I See Footnote Series C-1 Preferred Stock 2022-01-11 4 C 0 974107 0.00 D Common Stock 974107 0 I See Footnote Series C-2 Preferred Stock 2022-01-11 4 C 0 1621544 0.00 D Common Stock 1621544 0 I See Footnotes Upon the closing of the Issuer's initial public offering, all shares of Series A, Series B, Series C-1 and Series C-2 Preferred Stock (the "Preferred Stock") automatically converted into the number of shares of the Issuer's Common Stock shown in column 4 of Table I without payment or further consideration. The Preferred Stock had no expiration date. Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, are the directors of Morningside Venture Investments Limited ("Morningside") and share voting and dispositive power with respect to the securities held by Morningside and MVIL, LLC ("MVIL LLC"), Morningside's wholly-owned subsidiary. Cheng Yee Wing Betty and Wong See Wai are the managers of MVIL LLC and share voting and dispositive power with respect to the securities held by MVIL LLC. Ms. Cheng and Mr. Wong each disclaim ownership of the securities owned by MVIL LLC. The shares of Series C-2 Preferred Stock and the Common Stock received upon conversion of the C-2 Preferred Stock are held by MVIL LLC. The Reporting Persons are jointly filing this Form 4 pursuant to Rule 16a-3(j) under the Exchange Act. /s/ Frances Anne Elizabeth Richard, for Morningside Venture Investments Limited 2022-03-17 /s/ Cheng Yee Wing Betty, for MVIL, LLC 2022-03-17 EX-99 2 attachment1.htm EX-99 DOCUMENT

                             JOINT FILING AGREEMENT

The undersigned, MVIL, LLC is jointly filing the attached Form 4 with
MORNINGSIDE VENTURE INVESTMENTS LIMITED with respect to the beneficial ownership
of securities of Amylyx Pharmaceuticals, Inc.

For and on behalf of

MVIL, LLC


By: /s/ Cheng Yee Wing Betty
    -------------------------
Cheng Yee Wing Betty, Manager